MyAbilities Technologies, a company involved in smart health technology and workplace safety, has launched what is claimed to be the world's first online Digital Job Analysis database, JobXweb.com, it was reported yesterday.
The free database offers users access to more than 50,000 job titles, each with unique industry Digital Job Profiles including comprehensive analysis of the psychosocial, cognitive and physical demands in addition to a comprehensive job description. Each Digital Job Profile includes the essential demands of that job, whether they are physical, cognitive or psychosocial. Digital Job Profiles are shared with various stakeholders to support decisions leveraging the exact same set of data in a standardised, visual way to understand all the demands of the job.
Dr Michael Sonne, vice president, innovations and research at MyAbilities Technologies, said, 'Organisations can quickly search through a simple and free database to conduct a thorough review of the demands of thousands of jobs across all industries. We believe JobXweb.com is the first of its kind to offer easy access to a standardised analysis of thousands of jobs, and to present the information in a clear, shareable way.'
Sanofi's efdoralprin alfa receives EU orphan designation for AATD-related emphysema
Alcami completes third sterile fill-finish line at Research Triangle Park, NC
Black Buffalo partners with Sanova to support regulatory strategy and scientific innovation
Neurocrine Biosciences reveals new chapter in R&D strategy
Nicox completes key data package for NCX 470 NDA submissions
Immusoft's ISP-002 granted US FDA Orphan Drug Designation in MPS II
Orphan Therapeutics Accelerator signs MoU with Fondazione Telethon
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Physiomics secures follow-on UK contract for Phase 2 study support
Ascletis reports positive US Phase I data for oral IL-17 inhibitor ASC50
Dimerix completes adult recruitment in ACTION3 Phase 3 DMX-200 trial
RedHill Biopharma reports positive opaganib data in venetoclax-resistant CLL
Vanda files FDA Biologics License Application for imsidolimab in generalized pustular psoriasis
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
Sobi s Aspaveli marketing authorisation receives positive European regulatory opinion